Prestige BioPharma Limited (KRX: 950210)
South Korea
· Delayed Price · Currency is KRW
14,160
+360 (2.61%)
Oct 11, 2024, 3:19 PM KST
41.18% (1Y)
Market Cap | 170.79B |
Revenue (ttm) | 689.08M |
Net Income (ttm) | -32.92B |
Shares Out | 12.02M |
EPS (ttm) | -547.81 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 99,087 |
Open | 13,800 |
Previous Close | 13,800 |
Day's Range | 13,470 - 14,310 |
52-Week Range | 7,610 - 16,220 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Sep 19, 2024 |